|
2011
|
P 005091
|
Inhibitor of deubiquitinase USP7 and USP47 |
€95.00 |
|
1906
|
P 22077
|
Inhibitor of deubiquitinase USP7 and USP47 |
€95.00 |
|
1936
|
P 505-15
|
Inhibitor of spleen tyrosine kinase (Syk) |
€90.00 |
|
1090
|
p-MPPF dihydrochloride
|
5-HT1A antagonist |
€110.00 |
|
1091
|
p-MPPI
|
5-HT1A antagonist |
€110.00 |
|
1958
|
P2Y14 Antagonist Prodrug 7j hydrochloride
|
Prodrug of P2Y14 receptor antagonist |
€140.00 |
|
4189
|
P3FI-63
|
KDM3B inhibitor |
Recently added
|
€60.00 |
|
4190
|
P3FI-90
|
KDM3B inhibitor |
Recently added
|
€120.00 |
|
2602
|
P7C3
|
Proneurogenic and neuroprotective compound that activates NAMPT |
€105.00 |
|
1743
|
PAC 1
|
Procaspase activating compound 1 |
€80.00 |
|
2052
|
Palbociclib isethionate
|
Orally active cyclin-dependent kinase (CDK4/6) inhibitor |
€125.00 |
|
1211
|
Palmitoylethanolamide
|
Endocannabinoid; GPR55 agonist |
€75.00 |
|
1718
|
Palomid 529
|
mTOR inhibitor |
€90.00 |
|
3101
|
Palonosetron hydrochloride
|
Highly potent, selective and orally active 5-HT3 antagonist |
€150.00 |
|
3840
|
Paltusotine
|
Potent, selective, and orally bioavailable SST2 agonist |
€240.00 |
|
4064
|
Paltusotine dihydrochloride
|
Potent, selective, and orally bioavailable SST2 agonist |
€160.00 |
|
3161
|
Pantoprazole sodium
|
Proton pump inhibitor (PPI) |
€50.00 |
|
3311
|
Parecoxib sodium
|
Prodrug of Valdecoxib; selective COX-2 inhibitor |
€50.00 |
|
1482
|
Parogrelil
|
PDE3 inhibitor |
€120.00 |
|
1452
|
Paroxetine hydrochloride
|
SSRI |
€75.00 |
|
3614
|
Parthenolide
|
NF-κB activation inhibitor |
€90.00 |
|
3152
|
PAWI-2
|
Inhibitor which targets both Wnt signaling and ATM/p53 |
€120.00 |
|
3710
|
PAZ-417
|
Potent, orally active and CNS-penetrant PAI-1 inhibitor |
€130.00 |
|
1420
|
Pazopanib hydrochloride
|
PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor |
€60.00 |
|
1272
|
PB28 dihydrochloride
|
Sigma-2 agonist |
€85.00 |
|
3582
|
PBENZ-DBRMD
|
DIO3 inhibitor |
€120.00 |
|
4132
|
PBF-509
|
Selective Adenosine 2A receptor antagonist |
Inquire |
|
2626
|
PBTZ169
|
Potent irreversible DprE1 inhibitor; tuberculosis therapeutic |
€95.00 |
|
1858
|
PCI 32765
|
Inhibitor of Bruton's tyrosine kinase (BTK) |
€60.00 |
|
1853
|
PCI 34051
|
HDAC8 Inhibitor |
€90.00 |